Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “The Board of Regents of the University of Texas System”

1,742 pharma patents match "The Board of Regents of the University of Texas System" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 1,742
Index total 30,257
Page 16 / 73

Quick answer

This filtered view shows 1,742 pharmaceutical patents matching "The Board of Regents of the University of Texas System" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

1,742 results for “The Board of Regents of the University of Texas System” · 30,257 patents in full index Clear search

  1. US 11173227

    Wound dressings and applications thereof

    The Board of Regents of the University of Texas System · Granted Nov 16, 2021 · Expires Nov 11, 2041

    granted
  2. US 11174320

    HER3 specific monoclonal antibodies for diagnostic and therapeutic use

    The Board of Regents of the University of Texas System · Granted Nov 16, 2021 · Expires Nov 11, 2041

    granted
  3. US 11173145

    Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase

    The Board of Regents of the University of Texas System · Granted Nov 16, 2021 · Expires Nov 11, 2041

    granted
  4. US 11174495

    Reporter system for detecting and targeting activated cells

    The Board of Regents of the University of Texas System · Granted Nov 16, 2021 · Expires Nov 11, 2041

    granted
  5. US 11166962

    Methods and compositions comprising ursolic acid and/or resveratrol for treating diabetes, or cancer

    The Board of Regents of the University of Texas System · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted
  6. US 11166949

    NURR1 activation in the treatment of metabolic disorders and as an exercise mimetic

    The Board of Regents of the University of Texas System · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted
  7. US 11168142

    Administration of kynurenine depleting enzymes for tumor therapy

    The Board of Regents of the University of Texas System · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted
  8. US 11168325

    Methods for treatment of polycystic kidney disease

    The Board of Regents of the University of Texas System · Granted Nov 9, 2021 · Expires Nov 4, 2041

    granted
  9. US 11161875

    Inhibition of pulmonary fibrosis with nutlin-3a and peptides

    The Board of Regents of the University of Texas System · Granted Nov 2, 2021 · Expires Oct 28, 2041

    granted
  10. US 11162063

    Methods and apparatus for conditioning cell populations for cell therapies

    The Board of Regents of the University of Texas System · Granted Nov 2, 2021 · Expires Oct 28, 2041

    granted
  11. US 11162945

    Methods and compositions for detecting single T cell receptor affinity and sequence

    The Board of Regents of the University of Texas System · Granted Nov 2, 2021 · Expires Oct 28, 2041

    granted
  12. US 11161908

    BAFF-R targeted chimeric antigen receptor-modified t-cells and uses thereof

    The Board of Regents of the University of Texas System · Granted Nov 2, 2021 · Expires Oct 28, 2041

    granted
  13. US 11155804

    Recombinant polypeptides comprising selenocysteine and method for producing the same

    The Board of Regents of the University of Texas System · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted
  14. US 11155599

    Adenoviruses expressing heterologous tumor-associated antigens

    The Board of Regents of the University of Texas System · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted
  15. US 11154572

    Methods of treatment with natural killer cells matched for killer immunoglobulin receptor type

    The Board of Regents of the University of Texas System · Granted Oct 26, 2021 · Expires Oct 21, 2041

    granted
  16. US 11142764

    Antisense antibacterial compounds and methods

    The Board of Regents of the University of Texas System · Granted Oct 12, 2021 · Expires Oct 7, 2041

    granted
  17. US 11141418

    Methods and compositions for KRAS inhibitors

    The Board of Regents of the University of Texas System · Granted Oct 12, 2021 · Expires Oct 7, 2041

    granted
  18. US 11136613

    Antibacterial polypeptide libraries and methods for screening the same

    The Board of Regents of the University of Texas System · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted
  19. US 11136405

    BAFF-R antibodies and uses thereof

    The Board of Regents of the University of Texas System · Granted Oct 5, 2021 · Expires Sep 30, 2041

    granted
  20. US 11130772

    CYP-eicosanoid derivatives

    The Board of Regents of the University of Texas System · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted
  21. US 11129811

    Methods and compositions to prevent or treat bacterial infections

    The Board of Regents of the University of Texas System · Granted Sep 28, 2021 · Expires Sep 23, 2041

    granted
  22. US 11123334

    Compositions and methods for treating opioid overdose and opioid abuse

    The Board of Regents of the University of Texas System · Granted Sep 21, 2021 · Expires Sep 16, 2041

    granted
  23. US 11124489

    EPAC antagonists

    The Board of Regents of the University of Texas System · Granted Sep 21, 2021 · Expires Sep 16, 2041

    granted
  24. US 11118167

    Enzyme-mediated depletion of adenosine and/or methylthioadenosine

    The Board of Regents of the University of Texas System · Granted Sep 14, 2021 · Expires Sep 9, 2041

    granted